In addition, exogenous IL-6 activated the p-JAK2/p-STAT3 pathway but did not increase the protein expression of ALKBH5 in NSCLC cells, suggesting that IL-6 has no direct regulatory effect on ALKBH5 (Fig. 7E). This evidence concerns the gene JAK2 and non-small cell lung carcinoma.